249 related articles for article (PubMed ID: 11189510)
81. Interleukin-2 before and/or after autologous bone marrow transplantation for pediatric acute leukemia patients.
Messina C; Zambello R; Rossetti F; Gazzola MV; Varotto S; Destro R; Basso G; Semenzato G; Zanesco L
Bone Marrow Transplant; 1996 May; 17(5):729-35. PubMed ID: 8733689
[TBL] [Abstract][Full Text] [Related]
82. Detection of occasional and clonal chromosome aberrations in patients with acute non-lymphocytic leukemia after autologous bone marrow transplantation.
Testoni N; Martinelli G; Zaccaria A; Miggiano MC; Pelliconi S; Visani G; Manfroi S; Gherlinzoni F; Mangianti S; Tura S
Bone Marrow Transplant; 1996 Dec; 18(6):1141-5. PubMed ID: 8971385
[TBL] [Abstract][Full Text] [Related]
83. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M
Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281
[TBL] [Abstract][Full Text] [Related]
84. Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia.
Porcellini A; Manna A; Moretti L; Carotenuto M; Greco MM; Bodenizza C
Bone Marrow Transplant; 1989 May; 4(3):331-3. PubMed ID: 2659120
[No Abstract] [Full Text] [Related]
85. New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis.
Imrie KR; Dubé I; Prince HM; Girouard C; Crump M; Keating A
Bone Marrow Transplant; 1998 Feb; 21(4):395-9. PubMed ID: 9509975
[TBL] [Abstract][Full Text] [Related]
86. Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.
Phillips GL; Shepherd JD; Barnett MJ; Lansdorp PM; Klingemann HG; Spinelli JJ; Nevill TJ; Chan KW; Reece DE
J Clin Oncol; 1991 Oct; 9(10):1880-8. PubMed ID: 1919638
[TBL] [Abstract][Full Text] [Related]
87. Double intensification including autologous bone marrow transplantation (ABMT) in AML: long term follow-up and detection of residual disease.
Dicke KA; Dicke-Evinger MJ; Spinolo JA; Estey EH; Kantarjian HM; Spitzer GS
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():27-34. PubMed ID: 2390639
[No Abstract] [Full Text] [Related]
88. [Autologous transplantation in acute lymphoblastic leukemia in adults].
Piatkowska-Jakubas B; Wegrzyn J; Rucińska M; Skotnicki AB
Przegl Lek; 1999; 56 Suppl 1():52-6. PubMed ID: 10494183
[TBL] [Abstract][Full Text] [Related]
89. Autologous bone marrow transplantation for extramedullary relapse in childhood leukemia. The AIEOP Group and the FONOP. Italian Association of Pediatric Hemato/Oncology.
Messina C; Rondelli R; Valsecchi MG; Rossetti F; Miniero R; Meloni G; Locatelli F; Aricò M; Testi AM; Dini G; Arrighini A; Manfredini L; Dallorso S; Porta F; Uderzo C; Santoro N; Werner B; De Rossi G; Loiacono G; Andolina M; Lippi A; Favre C; Amici A; Lo Curto M; Masera G
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():40-2. PubMed ID: 8932797
[TBL] [Abstract][Full Text] [Related]
90. Successful treatment of primary extramedullary leukemia (EML) of the uterus with radical surgery, chemotherapy, autologous bone marrow transplantation (BMT) and prophylactic local irradiation.
Huter O; Brezinka C; Nachbaur D; Schwaighofer H; Lang A; Niederwieser D
Bone Marrow Transplant; 1996 Sep; 18(3):663-4. PubMed ID: 8879638
[TBL] [Abstract][Full Text] [Related]
91. Allogenic bone marrow transplantation for leukemias and aplastic anemia.
Tsai TW; Freytes CO
Adv Intern Med; 1997; 42():423-51. PubMed ID: 9048126
[TBL] [Abstract][Full Text] [Related]
92. Busulphan, cyclophosphamide, and melphalan as conditioning therapy in allogeneic bone marrow transplants for acute lymphoblastic leukemia.
Russell S; Vowels M
Transplant Proc; 1992 Feb; 24(1):183. PubMed ID: 1539236
[No Abstract] [Full Text] [Related]
93. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727
[TBL] [Abstract][Full Text] [Related]
94. ABMT for early isolated extramedullary relapse of childhood ALL.
Rossetti F; Messina C; Miniero R; Busca A; Sotti G; Cesaro S; Zanesco L; Colleselli P; Scotti G [corrected to Sotti G]
Bone Marrow Transplant; 1993 Jul; 12(1):37-41. PubMed ID: 8374535
[TBL] [Abstract][Full Text] [Related]
95. Double autologous bone marrow transplantation in acute myeloid leukaemia.
Gribben JG; Goldstone AH; Linch DC; MacMillan AK; Richards JD
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():209-11. PubMed ID: 2653506
[No Abstract] [Full Text] [Related]
96. TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission.
Biagi E; Rovelli A; Balduzzi A; De Lorenzo P; Tagliabue A; Uderzo C
Bone Marrow Transplant; 2000 Dec; 26(11):1260-2. PubMed ID: 11149746
[No Abstract] [Full Text] [Related]
97. Hematological recovery after autologous bone marrow transplantation in acute leukemia: predictive factors.
Canals C; Marti JM; Martinez E; Sierra J; Punti C; Granena A; Domingo A; Cubells J; Brunet S; Badell I
J Hematother; 1993; 2(1):75-85. PubMed ID: 7921968
[TBL] [Abstract][Full Text] [Related]
98. Aggressive chemotherapy for acute leukemia relapsed after transplantation.
Sica S; Salutari P; Di Mario A; D'Onofrio G; Etuk B; Leone G
Leuk Lymphoma; 1994 Sep; 15(1-2):131-4. PubMed ID: 7858490
[TBL] [Abstract][Full Text] [Related]
99. Are new conditioning regimens for transplants in acute myelogenous leukemia better?
Aurer I; Gale RP
Bone Marrow Transplant; 1991 Apr; 7(4):255-61. PubMed ID: 2070130
[TBL] [Abstract][Full Text] [Related]
100. High-dose chemotherapy with autologous stem cell transplantation is feasible and safe in a regional hospital. A 6-year experience in southern Switzerland.
Regazzoni S; Marini G; Grob A; Pedrazzini A; Goldhirsch A; Castelli D; Cavalli F; Ghielmini M
Bone Marrow Transplant; 1997 Jan; 19(1):3-7. PubMed ID: 9012924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]